Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q2)May 31, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q2)May 31, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q2)May 31, 2022 | (FY)Nov 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | --42.61K | --42.61K | ---- | ---- | ---- | ---- | ---- | ---- | 0.04%4.95K | ---- |
-Cash and cash equivalents | --42.61K | --42.61K | ---- | ---- | ---- | ---- | ---- | ---- | 0.04%4.95K | ---- |
Receivables | 0.22%2.49M | 0.22%2.49M | -45.69%2.61M | -17.32%2.49M | -17.32%2.49M | 2.12%4.81M | -49.07%3.01M | --3.01M | 8.00%4.71M | 48.99%5.91M |
Other assets | -13.60%2.03K | -13.60%2.03K | -13.43%14.34K | 0.00%2.35K | 0.00%2.35K | -0.01%16.57K | -0.09%2.35K | --2.35K | -8.61%16.57K | 4.54%2.35K |
Total assets | 4.63%162.18M | 4.63%162.18M | -12.72%155.82M | -11.76%155.01M | -11.76%155.01M | -7.77%178.53M | -20.35%175.67M | --175.67M | -11.26%193.57M | 5.34%220.55M |
Liabilities | ||||||||||
Payables | 397.71%9.67M | 397.71%9.67M | -86.25%543.25K | 175.22%1.94M | 175.22%1.94M | 75.34%3.95M | -91.03%706.04K | --706.04K | -51.38%2.25M | 799.55%7.87M |
-Accounts payable | -79.21%403.71K | -79.21%403.71K | -86.26%542.22K | 175.89%1.94M | 175.89%1.94M | 76.45%3.95M | -91.01%704.01K | --704.01K | -51.55%2.24M | 804.43%7.83M |
-Other payable | 1,053,034.55%9.27M | 1,053,034.55%9.27M | -64.62%1.03K | -56.71%880 | -56.71%880 | -81.55%2.91K | -94.88%2.03K | --2.03K | -4.75%15.8K | 335.64%39.68K |
Preferred securities outside stock equity | -14.95%51M | -14.95%51M | -14.22%59.99M | -14.22%59.97M | -14.22%59.97M | -6.59%69.94M | -6.60%69.91M | --69.91M | -0.17%74.88M | -0.20%74.85M |
Other liabilities | 12.29%118.72K | 12.29%118.72K | 3.24%86.42K | 1.11%105.72K | 1.11%105.72K | 3.80%83.71K | 9.96%104.56K | --104.56K | -7.57%80.64K | -9.69%95.09K |
Total liabilities | -1.97%60.79M | -1.97%60.79M | -18.05%60.62M | -12.30%62.01M | -12.30%62.01M | -4.19%73.97M | -14.61%70.72M | --70.72M | -3.15%77.21M | 9.00%82.82M |
Shareholders'equity | ||||||||||
Share capital | -0.03%115.11M | -0.03%115.11M | -7.60%115.14M | -7.60%115.14M | -7.60%115.14M | -0.05%124.61M | -0.05%124.61M | --124.61M | -0.02%124.67M | -0.02%124.67M |
-common stock | -0.03%115.11M | -0.03%115.11M | -7.60%115.14M | -7.60%115.14M | -7.60%115.14M | -0.05%124.61M | -0.05%124.61M | --124.61M | -0.02%124.67M | -0.02%124.67M |
Retained earnings | 38.08%-13.71M | 38.08%-13.71M | 0.54%-19.95M | -12.64%-22.15M | -12.64%-22.15M | -141.20%-20.06M | -250.52%-19.66M | ---19.66M | -160.64%-8.31M | 50.15%13.06M |
Total stockholders'equity | 9.03%101.39M | 9.03%101.39M | -8.95%95.19M | -11.39%92.99M | -11.39%92.99M | -10.14%104.56M | -23.80%104.95M | --104.95M | -15.93%116.36M | 3.26%137.74M |
Total equity | 9.03%101.39M | 9.03%101.39M | -8.95%95.19M | -11.39%92.99M | -11.39%92.99M | -10.14%104.56M | -23.80%104.95M | --104.95M | -15.93%116.36M | 3.26%137.74M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |